|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.25 TWD | +1.79% |
|
-.--% | - |
| 27/04 | UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 12/25/12 | UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 168.32Cr 5.19Cr 4.5Cr 4.18Cr 3.86Cr 7.27Cr 495.05Cr 7.4Cr 50Cr 19Cr 245.87Cr 19Cr 19Cr 826.84Cr | P/E 2024 |
-9.63x | P/E 2025 | -5.68x |
|---|---|---|---|---|---|
| Enterprise Value | 197.21Cr 6.08Cr 5.28Cr 4.9Cr 4.52Cr 8.51Cr 580.02Cr 8.67Cr 58Cr 23Cr 288.07Cr 23Cr 22Cr 968.75Cr | EV / Sales 2024 |
3.58x | EV / Sales 2025 | 3.83x |
| Free-Float |
27.79% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.79% |
| 3 years | 10 |  | 38.5 |
| 5 years | 10 | | 199.22 |
| 10 years | 8.34 | | 288.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jung Kuang Yang
CEO | Chief Executive Officer | - | - |
Meng Han Hsu
DFI | Director of Finance/CFO | - | 11/04/2016 |
Ying Yun Fan
ADM | Chief Administrative Officer | - | 01/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Yun Fan
BRD | Director/Board Member | - | 30/06/2020 |
Yan Ning Kuo
BRD | Director/Board Member | - | 30/06/2020 |
Yao Hui Wei
BRD | Director/Board Member | - | 30/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.79% | -.--% | -.--% | -58.47% | 5.19Cr | |
| -1.78% | -4.71% | +53.99% | +150.72% | 1,03000Cr | |
| -0.84% | -3.68% | +54.01% | +51.44% | 62TCr | |
| -2.65% | -2.66% | +33.56% | +68.77% | 45TCr | |
| -0.18% | -0.56% | +37.34% | +30.49% | 35TCr | |
| -0.22% | -0.27% | +34.37% | +38.97% | 30TCr | |
| -0.69% | -0.38% | +11.46% | +12.84% | 27TCr | |
| -7.65% | -4.32% | -2.46% | -43.83% | 23TCr | |
| -1.48% | +1.56% | +29.42% | +63.11% | 21TCr | |
| -1.20% | -0.22% | +14.90% | +69.46% | 16TCr | |
| Average | -1.54% | +4.79% | +26.66% | +38.35% | 36.13TCr | |
| Weighted average by Cap. | -1.70% | +4.87% | +38.35% | +71.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 54Cr 1.66Cr 1.44Cr 1.34Cr 1.23Cr 2.33Cr 158.48Cr 2.37Cr 16Cr 6.21Cr 79Cr 6.23Cr 6.1Cr 264.69Cr | 51Cr 1.58Cr 1.38Cr 1.28Cr 1.18Cr 2.22Cr 151.3Cr 2.26Cr 15Cr 5.93Cr 75Cr 5.95Cr 5.82Cr 252.7Cr |
| Net income | -17Cr -53.76L -46.7L -43.37L -39.99L -75.33L -51Cr -76.7L -5.13Cr -2.01Cr -25Cr -2.02Cr -1.97Cr -86Cr | -30Cr -91.28L -79.28L -73.62L -67.9L -1.28Cr -87Cr -1.3Cr -8.72Cr -3.41Cr -43Cr -3.43Cr -3.35Cr -145.54Cr |
| Net Debt | 25Cr 75.89L 65.92L 61.22L 56.46L 1.06Cr 72Cr 1.08Cr 7.25Cr 2.84Cr 36Cr 2.85Cr 2.79Cr 121.01Cr | 29Cr 89L 77.3L 71.79L 66.2L 1.25Cr 85Cr 1.27Cr 8.5Cr 3.33Cr 42Cr 3.34Cr 3.27Cr 141.91Cr |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- 6562 Stock
Select your edition
All financial news and data tailored to specific country editions
